Caniverm, tabletės
Caniverm, tabletės
Authorised
- Fenbendazole
- Pyrantel embonate
- Praziquantel
Product identification
Medicine name:
Caniverm, tabletės
Active substance:
- Fenbendazole
- Pyrantel embonate
- Praziquantel
Target species:
-
Cat
-
Dog
-
Wolf
-
Lion
-
Jackal
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Fenbendazole150.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Praziquantel50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Not applicable0day
-
-
Dog
-
Not applicable0day
-
-
Wolf
-
Not applicable0day
-
-
Lion
-
Not applicable0day
-
-
Jackal
-
Not applicable0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52A
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 16/07/2024